CHICAGO, Oct 20 (Reuters) - Shares of Boston Scientific
Corp (BSX.N) plummeted as much as 17 percent on Tuesday, wiping
out $2.55 billion of market value, after the company cut its
profit outlook and its chief executive warned of dire
consequences from a proposed health reform tax.